These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26560982)

  • 1. Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.
    Mizoguti Dde F; Hungria EM; Freitas AA; Oliveira RM; Cardoso LP; Costa MB; Sousa AL; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):914-20. PubMed ID: 26560982
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
    Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.
    Freitas AA; Oliveira RM; Hungria EM; Cardoso LP; Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):154-61. PubMed ID: 26233487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.
    Duthie MS; Raychaudhuri R; Tutterrow YL; Misquith A; Bowman J; Casey A; Balagon MF; Maghanoy A; Beltran-Alzate JC; Romero-Alzate M; Cardona-Castro N; Reed SG
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):233-9. PubMed ID: 24666703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients.
    Zenha EM; Ferreira MA; Foss NT
    Braz J Med Biol Res; 2009 Oct; 42(10):968-72. PubMed ID: 19784481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.
    Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F
    Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-PGL-1 antibody levels in Thai leprosy patients.
    Kampirapap K; Singtham N
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):728-33. PubMed ID: 9253875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.
    Serrano-Coll H; Muñoz M; Camilo Beltrán J; Duthie MS; Cardona-Castro N
    Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):125-131. PubMed ID: 28633333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to phenolic glycolipid by ELISA in leprosy patients.
    Lal H; Jain VK; Mittal RA; Chaudhary SD; Saini V
    Indian J Lepr; 1993; 65(1):95-9. PubMed ID: 8463728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.